Semaglutide biosimilar(Hangzhou Jiuyuan Gene Engineering))

司美格鲁肽生物类似药（杭州九源基因工程）

Report date: 2026/02/25 13:42:00

Base Information

Drug NameSemaglutide biosimilar(Hangzhou Jiuyuan Gene Engineering))
Drug Alias Namesemaglutida索马鲁肽semaglutidum索玛鲁肽司美鲁肽 +[9] 
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightBody WeightObesity +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesHangzhou Jiuyuan Gene Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Fosun Pharmaceutical (Group) Co LtdHangzhou Jiuyuan Gene Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsOverweightBody WeightObesity +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeA10BJ06
Related LinksWikipediaDrugBankKEGG